13F Holdings
中文EN

MDXR MEDICAL EXERCISE INC.

Services-Health Services · OTC · SEC CIK 2001249 · Fiscal year ends 03/31

Financial factors as of 2025-03-31 (2025Q4), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY—
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin65.6%
Operating margin65.6%
Net margin-25,578.4%
FCF margin-15,061.5%
EBITDA margin953.8%

Returns

ROE—
ROA-507.2%
ROIC (approx.)—
Asset turnover0.02x

Leverage & solvency

Liabilities / assets203.1%
Debt / equity—
Current ratio0.00x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.58x
Accruals ratio-214.5%
Payout ratio—
Capex / revenue299.0%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20262026-03-31FY20252025-03-31
Income statement
Revenue—$1,294
Cost of revenue—$445
Gross profit—$849
SG&A expense—$176,271
Operating income-$222,363-$331,374
Pretax income-$226,708-$330,985
Net income-$226,708-$330,985
EBITDA-$213,627-$319,882
EPS (basic)-0.02-0.03
EPS (diluted)-0.02-0.03
Weighted avg. shares (diluted)12.60M12.19M
Balance sheet
Cash & equivalents$43,449$450
Current assets$43,449$450
PP&E, net$15,924$59,903
Intangibles$1,957$4,908
Total assets$61,330$65,261
Current liabilities$244,837$132,560
Total liabilities$244,837$132,560
Shareholders' equity-$183,507-$67,299
Shares outstanding13.33M12.22M
Cash flow statement
Operating cash flow-$194,751-$191,027
Capital expenditure—$3,869
Free cash flow—-$194,896
Investing cash flow$33,849-$5,685
Financing cash flow$203,901$186,505
Depreciation & amortization$8,736$11,492
Stock-based compensation$2,000$100,000

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.